BioCentury
ARTICLE | Clinical News

ARC-520: Additional Phase IIa data

September 28, 2015 7:00 AM UTC

Top-line data from 6 treatment-naive hepatitis B e antigen (HBeAg)-positive patients with active chronic HBV infection in an open-label cohort of the double-blind, placebo-controlled, dose-escalation,...